Relationship between uremic toxins and oxidative stress in patients with chronic renal failure

References

• Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 363: 1934–43
   Google Scholar
• Slominska EM, Smolenski R, Szolkiewicz M, Leaver N, Rutkowski B, Simmonds H, et al. Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure. Mol Cell Biochem 2002; 231: 83–8
   PubMed Web of Science ®Google Scholar
• Rutkowski B, Swierczynski J, Slominska E, Szolkiewicz M, Smolenski RT, Marlewski M, et al. Disturbances of purine nucleotide metabolism in uremia. Semin Nephrol 2004; 24: 479–83
   PubMed Web of Science ®Google Scholar
• Walters CJ, Brown RR, Kaihara M, Price JM. The excretion of N-methyl-2-pyridone-5-carboxamide by man following ingestion of several known or potential precursors. J Biol Chem 1955; 217: 489–95
   PubMed Web of Science ®Google Scholar
• Price JM. The determination of N-methyl-2-pyridone-5-carboxamide in human urine. J Biol Chem 1954; 211: 117–24
   PubMed Web of Science ®Google Scholar
• Abelson D, Boyle A, Depatie C, Seligson H. N′-methyl-2-pyridone-5-carboxamide in human plasma. Clin Chim Acta 1963; 82: 603–6
   Google Scholar
• Slominska EM, Rutkowski P, Smolenski RT, Szutowicz A, Rutkowski B, Swierczynski J. The age-related increase in N-methyl-2-pyridone-5-carboxamide (NAD catabolite) in human plasma. Mol Cell Biochem 2004; 267: 25–30
   PubMed Web of Science ®Google Scholar
• Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004; 65: 1009–16
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, McMonagle E. Manifestations of oxidant stress in uremia. Blood Purif 2001; 19: 200–5
   PubMed Web of Science ®Google Scholar
• Annuk M, Fellstrom B, Akerblom O, Zilmer K, Vihalemm T, Zilmer M. Oxidative stress markers in pre-uremic patients. Clin Nephrol 2001; 56: 308–14
   PubMed Web of Science ®Google Scholar
• Amann K, Tyralla K, Gross ML, Eifert T, Adamczak M, Ritz E. Special characteristics of atherosclerosis in chronic renal failure. Clin Nephrol 2003; 60(Suppl 1)S13–21
   PubMed Web of Science ®Google Scholar
• Ikizler TA. Role of nutrition for cardiovascular risk reduction in chronic kidney disease patients. Adv Chronic Kidney Dis 2004; 11: 162–71
   PubMed Web of Science ®Google Scholar
• Zoccali C, Mallamaci F, Tripepi G. Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol 2004; 15(Suppl 1)S77–80
   PubMed Web of Science ®Google Scholar
• Satoh M, Hayashi H, Watanabe M, Ueda K, Yamato H, Yoshioka T, et al. Uremic toxins overload accelerates renal damage in a rat model of chronic renal failure. Nephron Exp Nephrol 2003; 95: e111–8
   PubMed Web of Science ®Google Scholar
• Cohen G, Rudnicki M, Horl WH. Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils. Kidney Int Suppl 2001; 78: S48–52
   PubMedGoogle Scholar
• Deppisch RM, Beck W, Goehl H, Ritz E. Complement components as uremic toxins and their potential role as mediators of microinflammation. Kidney Int Suppl 2001; 78: S271–7
   PubMedGoogle Scholar
• Rutkowski B, Slominska E, Szolkiewicz M, Smolenski RT, Striley C, Rutkowski P, et al. N-methyl-2-pyridone-5-carboxamide: a novel uremic toxin?. Kidney Int Suppl 2003; 63: S19–21
   Google Scholar
• Malgorzewicz S, Lichodziejewska-Niemierko M, Rutkowski B, Lysiak-Szydlowska W. Nutritional status and oxidative processes in diabetic and nondiabetic peritoneal dialysis patients. J Ren Nutr 2004; 14: 242–7
   PubMed Web of Science ®Google Scholar
• Shibata K, Kawada T, Iwai K. Simultaneous micro-determination of nicotinamide and its major metabolites N′-methyl-2-pyridone-5-carboxamide and N′-methyl-4-pyridone-3-carboxamide, by high-performance liquid chromatography. J Chromatogr 1988; 424: 23–8
   PubMed Web of Science ®Google Scholar
• Anderson ME. Enzymatic and chemical method for the determination of glutathione. Glutathione: chemical, biochemical and medical aspects, Vol. A, D Dolphin, R Poulson, O Avramovic. John Wiley and Sons, New York 1989; 339–65
   Google Scholar
• Garibaldi S, Aragna I. Relationship between protein carbonyls, retinol and tocopherols level in human plasma. Biochem Mol Biol Int 1994; 34: 729–36
   PubMedGoogle Scholar
• Miyata T, Sugiyama S, Saito A, Kurokawa K. Reactive carbonyl compounds related uremic toxicity (“carbonyl stress”). Kidney Int Suppl 2001; 78: S25–31
   PubMedGoogle Scholar
• Miyata T, Kurokawa K, Van Ypersele De Strihou C. Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int 2000; 58: 120–5
   Web of Science ®Google Scholar
• Annuk M, Zilmer M, Lind L, Linde T, Fellstrom B. Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 2001; 12: 2747–52
   PubMed Web of Science ®Google Scholar
• Alhamdani MS. Impairment of glutathione biosynthetic pathway in uraemia and dialysis. Nephrol Dial Transplant 2005; 20: 124–8
   PubMed Web of Science ®Google Scholar
• Agarwal R, Vasavada N, Sachs NG, Chase S. Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Kidney Int 2004; 65: 2279–89
   PubMed Web of Science ®Google Scholar
• Nemeth I, Turi S, Haszon I, Bereczki C. Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis. Pediatr Nephrol 2000; 14: 13–7
   PubMed Web of Science ®Google Scholar
• Chen HC, Tsai JC, Tsai JH, Lai YH. Recombinant human erythropoietin enhances superoxide production by FMLP-stimulated polymorphonuclear leukocytes in hemodialysis patients. Kidney Int 1997; 52: 1390–4
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, McMenamin E, McMonagle E. Plasma aminothiol oxidation in chronic hemodialysis patients. Kidney Int 2002; 61: 705–16
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, McMonagle E, McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 2000; 58: 2571–8
   PubMed Web of Science ®Google Scholar